Long-term consequences after jejunoileal bypass for morbid obesity

Area of Science:

• Gastroenterology
• Bariatric Surgery
• Metabolic Surgery
• Long-term Health Outcomes

Background:

• Jejunoileal bypass (JIB) is a bariatric surgical procedure.
• Long-term effects and complications of JIB require continued investigation.
• Understanding sustained benefits versus late-onset complications is crucial for patient management.

Purpose of the Study:

• To assess the long-term outcomes of jejunoileal bypass (JIB) in patients with intact surgical bypass.
• To evaluate the maintenance of weight loss and improvements in physiological functions.
• To identify the incidence and progression of adverse effects and complications over more than 10 years post-surgery.

Main Methods:

• Prospective follow-up of 43 patients who underwent jejunoileal bypass (JIB).
• Data collection over an average of 12.6 years post-JIB.
• Assessment of weight, lipid levels, glucose tolerance, cardiac and pulmonary function, and various adverse effects.

Main Results:

• Sustained weight loss and improvements in lipid levels, glucose tolerance, cardiac, and pulmonary function were observed.
• Incidence of hypokalemia, cholelithiasis, and vitamin deficiencies decreased; diarrhea remained constant.
• Increased rates of hypomagnesemia (67% vs 43%), nephrolithiasis (33%), and progressive hepatic fibrosis (38%) were noted.

Conclusions:

• While JIB offers long-term benefits for some patients, including symptom alleviation, irreversible complications increase over time.
• Hepatic fibrosis is a significant and progressive risk, even in the late postoperative period.
• Long-term monitoring is essential for patients who have undergone JIB due to the persistent risk of serious complications.